Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 704

Results For "ED"

9088 News Found

ENPICOM launches versatile display data analysis solution to accelerate antibody selection
Biotech | May 25, 2022

ENPICOM launches versatile display data analysis solution to accelerate antibody selection

The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform


Piramal Pharma Solutions upgrades Pithampur site
News | May 25, 2022

Piramal Pharma Solutions upgrades Pithampur site

New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses


Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
Drug Approval | May 24, 2022

Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets

The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA


Lonza to expand inhalation capabilities at Tampa site
Biotech | May 24, 2022

Lonza to expand inhalation capabilities at Tampa site

Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers


HNZ Lifesciences unveils its new brand Amio Wellness
News | May 24, 2022

HNZ Lifesciences unveils its new brand Amio Wellness

The key categories include intimate wellness, skincare & hair care


AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases
Biotech | May 24, 2022

AbbVie showcases its leadership in Rheumatology research with new data across multiple inflammatory joint diseases

The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually


My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape
interviews | May 23, 2022

My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape

Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com


Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device
Healthcare | May 23, 2022

Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device

Objective tracking data combined with cohort data to drive medicine of the future


CHMP recommends European Commission approval of Rinvoq
Drug Approval | May 23, 2022

CHMP recommends European Commission approval of Rinvoq

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients


Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape
Biotech | May 23, 2022

Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape

The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer